LETROZOLE ACTAVIS 2.5mg Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole actavis 2.5mg

medis pharma pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE GH letrozole 2.5mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole gh letrozole 2.5mg film-coated tablet blister pack

cipla australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE SANDOZ Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole sandoz

sandoz pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; microcrystalline cellulose; titanium dioxide; macrogol 8000; sodium starch glycollate; maize starch; iron oxide yellow; colloidal anhydrous silica; lactose monohydrate; purified talc - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE FBM letrozole 2.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole fbm letrozole 2.5 mg film-coated tablet blister pack

southern cross pharma pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; sodium starch glycollate type a; maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - indicated for the treatment of post menopausal women with hormone receptor positive breast cancer. the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole cipla letrozole 2.5mg film-coated tablet blister pack

cipla australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE-WT letrozole 2.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole-wt letrozole 2.5 mg tablet blister pack

medis pharma pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of postmenopausal women with hormone receptor positive breast cancer (see "clinical trials"). the safety and efficacy of neoadjuvant use has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE ASCENT letrozole 2.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole ascent letrozole 2.5 mg tablet blister pack

medis pharma pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of postmenopausal women with hormone receptor positive breast cancer (see "clinical trials"). the safety and efficacy of neoadjuvant use has not been established. letrozole is not indicated in hormone receptor negative disease.

LETROZOLE WATSON letrozole 2.5 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole watson letrozole 2.5 mg film-coated tablets blister pack

medis pharma pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials).,the safety and efficacy of neoadjuvant use of letrozole has not been established.,letrozole is not indicated in hormone receptor negative disease.

LETROZOLE CH letrozole 2.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

letrozole ch letrozole 2.5 mg film-coated tablet blister pack

accord healthcare pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; microcrystalline cellulose; maize starch; titanium dioxide; hypromellose; macrogol 400 - treatment of postmenopausal women with hormone receptor positive breast cancer (see "clinical trials"). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.

ARX-LETROZOLE letrozole 2.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

arx-letrozole letrozole 2.5 mg film-coated tablet blister pack

cipla australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.